I want to let everyone know that Winsantor is continuing in its efforts to bring its first-of-a-kind disease modifying drug to market as well as implementing its FDA-sanctioned compassionate use program utilizing the drug while pending approval. It needs more people to sign up for this program before it can start the program. I received this communication from Winsantor today:

Phase 3 Trials: Progress and Next Steps In parallel, we have been working tirelessly to secure funding for our Phase 3 trials, which will involve approximately 700 patients globally. We are finalizing negotiations with several funding sources and expect to have the necessary resources soon. Once secured, we aim to launch both the Phase 3 trials and the Compassionate Use Program in the U.S. and other countries.